Venus Remedies share news, announcements and annual reports

NSE: VENUSREMBSE: 526953Pharmaceuticals & BiotechnologySmall Cap

Venus Remedies Limited · Face value ₹10 · Listed May 1995 on BSE, Dec 2006 on NSE

₹1,238.60₹50.70 (3.93%)BSE ₹1,231.75

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,289.30.

30 Oct: open ₹1,290.00, high ₹1,319.00, low ₹1,225.10

52-week range of traded prices to 30 Oct 2026

₹432.10Low, 31 Oct 2025₹2,044.30High, 29 Jun 2026

Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
Delivery only: shares bought must be paid for in full, with no selling on the same day.

Market cap: ₹1,656 Cr1,337th largest listed
P/E: 13.61
P/B: 2.35
Dividend yield: 0.81%
ROE: 18.7%
ROCE: 21.0%
Debt to equity: 0.00
Volume, NSE: 48,127

Venus Remedies board meetings

168 filed, newest first. Page 2 of 4.

Feb 2021
- 8 Feb · Board meeting
  Board meeting held on February 08, 2021 regarding approval of Unaudited financial results for the quarter and nine month ended 31.12.2020
Jan 2021
- 30 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2020
- 15 Jan · Board meeting
  Board meeting held on January 15, 2021.
- 7 Jan · Board meeting
  To consider other business matters
Nov 2020
- 6 Nov · Board meeting
  Board meeting held on November 06, 2020.
Oct 2020
- 30 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2020 and other business matters as per the enclosed notice.
Sep 2020
- 15 Sep · Board meeting
  Board meeting held on September 15, 2020.
- 5 Sep · Board meeting
  To consider and approve the financial results for the period ended June 30, 2020
Aug 2020
- 21 Aug · Board meeting
  Board meeting held on August 21, 2020.
Jul 2020
- 23 Jul · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020
Feb 2020
- 12 Feb · Board meeting
  Board meeting held on February 12, 2020. This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Unaudited Financial Results for the quarter ended on 31.12.2019. Meeting concluded at 7.40 pm.
- 1 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2019 and any other item with the permission of Chair.
Nov 2019
- 12 Nov · Board meeting
  Board meeting held on November 12, 2019.
Oct 2019
- 31 Oct · Board meeting
  This is to inform you that the meeting of Board of Directors is scheduled to be held on Tuesday, 12th November 2019 to inter alia consider and approve as below: 1. Unaudited Financial Results for the quarter ended on 30th September, 2019 2. Any other item with the permission of chair.Further, as informed vide letter dated 30.09.2019, the trading window would remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives, in view of the aforesaid Board meeting.
Aug 2019
- 13 Aug · Board meeting
  Board meeting held on August 13, 2019.
Jul 2019
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters
May 2019
- 30 May · Board meeting
  This has reference to the meeting of Board of Directors dated 29th May, 2019, which was adjourned and continued on 30th May, 2019 i.e. today inter alia considered and approved as follows: 1. Audited Financial Results standalone and consolidated for the quarter and year ended on 31.03.2019 along with Audit Report. 2. Secretarial Audit Report as on 31.03.2019. 3. The resignation of Dr. Rupinder Tewari, Non-Executive and Independent Director taken on record. Meeting concluded at 9:40 pm.
- 29 May · Board meeting
  With reference to the above, we hereby inform you that the meeting of Board of Directors of the Company held on Wednesday, 29th May 2019 is adjourned and will continue to be held on Thursday, 30th May 2019 to transact the agenda items. Further, the trading window would continue to remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives.
- 18 May · Board meeting
  This is to inform you that the meeting of Board of Directors is scheduled to be held on Wednesday, 29th May 2019 to inter alia consider and approve Audited Financial Results for the quarter and year ended on 31st March 2019 and any other item with the permission of chair.Further, as informed vide letter dated 04.04.2019, the trading window would remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives.
Feb 2019
- 14 Feb · Board meeting
  This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Unaudited Financial Results for the quarter ended on 31.12.2018.
- 4 Feb · Board meeting
  This is to inform you that the meeting of Board of Directors is scheduled to be held on Thursday, 14th February 2019 to inter alia consider and approve Unaudited Financial Results for the quarter ended on 31.12.2018 and any other item with the permission of chair.
Nov 2018
- 14 Nov · Board meeting
  Board meeting held on November 14, 2018.
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018 and any other item with the permission of chair.
Aug 2018
- 13 Aug · Board meeting
  Board meeting held on August 13, 2018.
- 2 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters
May 2018
- 28 May · Board meeting
  Board meeting held on May 28, 2018.
- 18 May · Board meeting
  This is to inform you that the meeting of Board of Directors is scheduled to be held on Monday, 28th May 2018 to inter alia consider and approve :1. Audited Financial results for the quarter and year ended on 31.03.2018.2. Any other item with the permission of Chairman.Further, pursuant to the provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, it has been decided to close the trading window for the dealing in the securities of the company listed at your exchange with effect from May 18, 2018 to May 30, 2018 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
Feb 2018
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2018.
- 2 Feb · Board meeting
  To inter alia consider and approve : 1. Unaudited Financial results for the quarter ended on December 31, 2017. 2. The resignation of Sh. Jagdish Chander, Independent Director. 3. The appointment of Sh. Pravindra Singh Chauhan as Non-Executive Independent Director of the Company. 4. The re-appointment of Mr. Ashutosh Jain as an Executive Director of the Company for five years.
Jan 2018
- 10 Jan · Board meeting
  To inter alia consider and approve: 1) To allot the shares to eligible Qualified Institutional Buyers under QIP issue. 2) To apply for listing approval with Stock Exchanges
- 9 Jan · Board meeting
  To inter alia consider and approve: 1) To take note of Bids received from the QIB 2) To close the QIP issue. 3)To allocate the number of shares to the QIB 4) To decide the Issue price for QIP issue. 5) To approve Placement Document for QIP issue.
- 5 Jan · Board meeting
  Inter alia consider and approve: 1) To approve date of opening and closing of QIP issue. 2) To approve Preliminary Placement Document for QIP issue. 3) To decide the Floor price and Issue price for QIP issue.
Dec 2017
- 7 Dec · Board meeting
  Outcome of Board Meeting held on December 07, 2017.
Nov 2017
- 30 Nov · Board meeting
  To inter alia consider and approve Unaudited Financial Results for the quarter ended on September 30, 2017 and any other item with the permission of chair.
Sep 2017
- 1 Sep · Board meeting
  Outcome of Board Meeting held on September 01, 2017.
Aug 2017
- 30 Aug · Board meeting
  Company had now informed the Exchange that the meeting of the Company scheduled to be held on September 01, 2017 to inter alia consider and approve Unaudited Financial Results for the quarter ended on June 30, 2017 and any other item with the permission of chair. The Company has now informed the Exchange that the Board Meeting also to be included: (1). To approve date of opening of QIP issue. (2). To approve Preliminary Placement Document for QIP issue. (3.) To decide the Floor price for QIP issue. (Purpose Revised).
  Not held on this date
- 12 Aug · Board meeting
  To inter alia consider and approve Unaudited Financial Results for the quarter ended on June 30, 2017 and any other item with the permission of chair.
- 4 Aug · Board meeting
  To inter alia consider and approve Unaudited Financial Results for the quarter ended on June 30, 2017 and any other item with the permission of chair.
  Not held on this date
- 2 Aug · Board meeting
  To inter alia consider & approve the relevant date with regard to issue of equity shares under Qualified Institutional Placement and any other item with the permission of chair.
May 2017
- 20 May · Board meeting
  To inter alia consider and approve Audited Financial Results for the quarter & year ended on 31.03.2017 and any other item with the permission of chair.
Apr 2017
- 13 Apr · Board meeting
  Board of Directors of the Company in its meeting held on April 13, 2017 have appointed M/s Prem Garg & Associates, Chartered Accountants as statutory auditors of the Company as per section 139 of the Companies Act, 2013, w.e.f. April 1, 2017 subject to approval in shareholders' meeting.
- 10 Apr · Board meeting
  To inter alia appoint statutory auditor under section 139 of the Companies Act, 2013 and any other item with the permission of chair. Further, pursuant to the provisions of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, it has been decided to close the trading window for the dealing in the securities of the company listed at your exchange with effect from April 10, 2017 to April 15, 2017 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
Mar 2017
- 20 Mar · Board meeting
  Board of Directors of the Company in its meeting held on March 20, 2017 have allotted 9,00,000 Equity Shares of face value of Rs. 10 each at a price of Rs. 88.77 (Rupees Eighty Eight and seventy seven paise only) to promoters of the Company on conversion of fully convertible warrants on preferential basis.
- 15 Mar · Board meeting
  To inter alia allot 9,00,000 equity shares on conversion of fully convertible warrants to Promoters on preferential basis and any other item with the permission of chair.
Feb 2017
- 17 Feb · Board meeting
  To inter alia consider and approve raising of funds by way of Qualified Institutional Placement (QIP) and any other item with the permission of chair.
- 8 Feb · Board meeting
  His is to inform you that, the Board of Directors of the Company at its meeting held February 08, 2017 has allotted 9,00,000 warrants fully convertible into equity shares to promoters on preferential basis.
Jan 2017
- 30 Jan · Board meeting
  To inter alia consider and approve Unaudited Financial Results (Provisional) for the quarter ended on December 31, 2016, to allot warrants/equity shares to promoters of the company on preferential basis and any other item with the permission of chair.
Nov 2016
- 1 Nov · Board meeting
  To inter alia consider and approve Unaudited Financial Results (Provisional) for the quarter ended on September 30, 2016 and any other item with the permission of chair.
Aug 2016
- 6 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 6, 2016 inter alia considered and approved following items:1. To issue fully convertible warrants/equity shares to promoters on a preferential basis subject to approval in the general meeting.2. Fixation of date of Annual General Meeting as September 29, 2016 3. Approved Corporate Governance report, Directors report and AGM notice;
Jul 2016
- 27 Jul · Board meeting
  To inter alia consider and approve : 1. Unaudited financial results (provisional) for the quarter ended June 30, 2016 2. To issue fully convertible warrants/equity shares to promoters on a preferential basis subject to approval in the general meeting. 3. To fix the date of Annual General Meeting and book closure. 4. To consider any other business with the permission of the Chair.

Venus Remedies board meetings

Feb 2021

Jan 2021

Nov 2020

Oct 2020

Sep 2020

Aug 2020

Jul 2020

Feb 2020

Nov 2019

Oct 2019

Aug 2019

Jul 2019

May 2019

Feb 2019

Nov 2018

Aug 2018

May 2018

Feb 2018

Jan 2018

Dec 2017

Nov 2017

Sep 2017

Aug 2017

May 2017

Apr 2017

Mar 2017

Feb 2017

Jan 2017

Nov 2016

Aug 2016

Jul 2016